Lee Virginia M-Y, Kenyon Theresa K, Trojanowski John Q
University of Pennsylvania School of Medicine, Pathology, 3600 Spruce Street, HUP, 3rd Floor Maloney Building 1914104-4283, Philadelphia, PA, USA.
Biochim Biophys Acta. 2005 Jan 3;1739(2-3):251-9. doi: 10.1016/j.bbadis.2004.06.014.
Tauopathies are a group of neurodegenerative disorders that include Alzheimer's disease, frontotemporal dementia with parkinsonism linked to chromosome 17 (FTDP-17) and other related diseases with prominent tau pathology. Research advances in the last several decades have characterized and defined tau neuropathologies of both neuron and glia in these diverse disorders and this has stimulated development of animal models of tauopathies. Indeed, animal models ranging from invertebrate species such as C. elegan to Drosophila melanogaster and mammalian transgenic mouse models of tauopathies have been generated and reported. This review summarizes the salient features of many of the known models of tauopathies.
tau蛋白病是一组神经退行性疾病,包括阿尔茨海默病、与17号染色体相关的额颞叶痴呆伴帕金森综合征(FTDP - 17)以及其他具有显著tau蛋白病理特征的相关疾病。过去几十年的研究进展已经明确了这些不同疾病中神经元和胶质细胞的tau蛋白神经病理学特征,这推动了tau蛋白病动物模型的发展。事实上,已经建立并报道了从无脊椎动物如秀丽隐杆线虫到果蝇以及tau蛋白病的哺乳动物转基因小鼠模型等各种动物模型。这篇综述总结了许多已知tau蛋白病模型的显著特征。